The information requested is not available but reporting of clinically-significant glycopeptide resistant enterococci bloodstream infection has been mandatory for national health service acute trusts in England since September 2003.
Glycopeptide resistant enterococci (GRE) include organisms that are resistant to either vancomycin or teicoplanin and the available data are shown as follows.
Reporting year (October to September each year) Number of GRE bloodstream infection reports 2003-04 628 2004-05 757 2005-06 903 2006-07 910 Source: Health Protection Agency
The information requested is not collected.
The information requested is not available.
A prevalence study, commissioned by the Department, carried out in 2006, showed that surgical site infection accounted for 14.5 per cent. of the healthcare-associated infections.